Ford Financial Group, LLC Abb Vie Inc. Transaction History

Ford Financial Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	SELL	$131.98 - $163.75 $36,426 - $45,195	-276 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $29,650 - $37,516	276 New	276 $37,000
Q3 2021 Nov 05, 2021	SELL	$106.4 - $120.78 $44,794 - $50,848	-421 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $44,293 - $49,345	421 New	421 $47,000
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $63,394 - $84,891	-689 Closed	0 $0

Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $61,706 - $67,666	689	689 $68,000

4,489

1.28B

16.9M

15.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $414B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Ford Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Ford Financial Group, LLC with notifications on news.